Webinar Date/Time: Thu, Mar 21, 2024 11:00 AM EDT
Join this webinar to explore the complexities of subcutaneous injections for protein and antibody therapeutics and learn how to navigate molecular challenges to optimize formulation for high concentration solutions.
Register Free: https://www.biopharminternational.com/bp_w/high-concentration-protein
Event Overview:
Subcutaneous injection presents many advantages over IV administration. Yet, attaining the required concentrations for such injections proves daunting, particularly for protein and antibody-based therapeutics. Concentrated protein and antibody solutions can become highly viscous, form undesirable high molecular weight aggregates, or precipitate. In this webinar, we critically review the molecular intricacies behind these challenges and propose a systematic exploration of the formulation space to identify excipients conducive to high concentration formulations.
Key Learning Objectives:
Who Should Attend:
Speaker:
Axel Müller, PhD
Senior Research Scientist III Formulation
Curia
Dr. Axel Müller joined Curia in 2021. His team manages a range of formulation projects, from early-stage development to compatibility studies. He earned his PhD in protein X-ray crystallography from the University of York, UK, and researched membrane proteins at Caltech.
Register Free: https://www.biopharminternational.com/bp_w/high-concentration-protein
EXO Biologics and ExoXpert Reach Two Critical Milestones that Advance Exosomes
December 3rd 2024EXO Biologics and its subsidiary, ExoXpert, have received GMP certification of a European exosomes manufacturing facility and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.